KR20240004303A - 항균제 및 항암제 - Google Patents
항균제 및 항암제 Download PDFInfo
- Publication number
- KR20240004303A KR20240004303A KR1020237035237A KR20237035237A KR20240004303A KR 20240004303 A KR20240004303 A KR 20240004303A KR 1020237035237 A KR1020237035237 A KR 1020237035237A KR 20237035237 A KR20237035237 A KR 20237035237A KR 20240004303 A KR20240004303 A KR 20240004303A
- Authority
- KR
- South Korea
- Prior art keywords
- cancer
- subject
- compound
- compounds
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D291/00—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
- C07D291/02—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms not condensed with other rings
- C07D291/06—Six-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163181492P | 2021-04-29 | 2021-04-29 | |
| US63/181,492 | 2021-04-29 | ||
| PCT/IB2022/053973 WO2022229907A1 (en) | 2021-04-29 | 2022-04-28 | Antimicrobial and anticancer agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20240004303A true KR20240004303A (ko) | 2024-01-11 |
Family
ID=81598080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020237035237A Pending KR20240004303A (ko) | 2021-04-29 | 2022-04-28 | 항균제 및 항암제 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12612375B2 (https=) |
| EP (1) | EP4330238A1 (https=) |
| JP (1) | JP2024515215A (https=) |
| KR (1) | KR20240004303A (https=) |
| CN (1) | CN117295720A (https=) |
| AU (1) | AU2022267897A1 (https=) |
| CA (1) | CA3216783A1 (https=) |
| IL (1) | IL307990A (https=) |
| WO (1) | WO2022229907A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024177036A1 (ja) * | 2023-02-20 | 2024-08-29 | 大鵬薬品工業株式会社 | Ftd・tpi配合剤、pd-1経路アンタゴニスト、及びvegf経路アンタゴニストの併用 |
| WO2026074499A1 (en) * | 2024-10-03 | 2026-04-09 | Geistlich Pharma Ag | Methods and compositions for inhibiting c-myc |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1160443B (de) * | 1961-11-30 | 1964-01-02 | Hoechst Ag | Verfahren zur Herstellung von Tetrahydro-oxathiazin-dioxyden |
| GB8617482D0 (en) | 1986-07-17 | 1986-08-28 | Geistlich Soehne Ag | Pharmaceutical composition |
| PT2861573T (pt) | 2012-06-18 | 2017-11-14 | Geistlich Pharma Ag | Derivados de oxatiazina como agentes antibacterianos e anticancerígeno |
| KR102594322B1 (ko) * | 2014-12-19 | 2023-10-26 | 가이스틀리히 파마 아게 | 옥사티아진-유사 화합물의 제조방법 |
| US20220313702A1 (en) | 2019-05-22 | 2022-10-06 | Geistlich Pharma Ag | Oxathiazin compounds for inhibiting gapdh |
-
2022
- 2022-04-28 AU AU2022267897A patent/AU2022267897A1/en not_active Abandoned
- 2022-04-28 WO PCT/IB2022/053973 patent/WO2022229907A1/en not_active Ceased
- 2022-04-28 KR KR1020237035237A patent/KR20240004303A/ko active Pending
- 2022-04-28 CA CA3216783A patent/CA3216783A1/en active Pending
- 2022-04-28 JP JP2023565466A patent/JP2024515215A/ja active Pending
- 2022-04-28 EP EP22722576.0A patent/EP4330238A1/en active Pending
- 2022-04-28 US US18/556,480 patent/US12612375B2/en active Active
- 2022-04-28 CN CN202280031909.6A patent/CN117295720A/zh active Pending
- 2022-04-28 IL IL307990A patent/IL307990A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US12612375B2 (en) | 2026-04-28 |
| JP2024515215A (ja) | 2024-04-05 |
| IL307990A (en) | 2023-12-01 |
| US20240199563A1 (en) | 2024-06-20 |
| CN117295720A (zh) | 2023-12-26 |
| AU2022267897A1 (en) | 2023-11-02 |
| CA3216783A1 (en) | 2022-11-03 |
| EP4330238A1 (en) | 2024-03-06 |
| WO2022229907A1 (en) | 2022-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7449913B2 (ja) | オキサチアジン様化合物を作製する方法 | |
| EP2861573B1 (en) | Oxathiazine derivatives as antibacterial and anticancer agents. | |
| EP3188721B1 (en) | Human therapeutic agents | |
| US20120316203A1 (en) | Compositions and Methods for Inhibition of Cancers | |
| KR20240004303A (ko) | 항균제 및 항암제 | |
| US12534443B2 (en) | Processes for preparing oxathiazin-like compounds | |
| WO2015150839A1 (en) | Glycolipids and pharmaceutical compositions thereof for use in therapy | |
| EA007506B1 (ru) | Применение акрилоильных производных дистамицина для лечения опухолей, связанных с высокими уровнями глутатиона | |
| EP4565240A1 (en) | Combination therapy for treating cancers | |
| CN113993515A (zh) | 使用藏红花酸治疗实体肿瘤的方法 | |
| HK40076913A (en) | Processes for preparing oxathiazin-like compounds | |
| KR20060136219A (ko) | 시스플라틴과 녹차 추출물을 포함하는 항암 조성물 | |
| KR20060078343A (ko) | 데커신 및/또는 데커시놀 안젤레이트, 또는 데커신및/또는 데커시놀 안젤레이트를 유효성분으로 하는당귀추출물을 포함하는 항암제 조성물 | |
| KR20070000249A (ko) | 시스플라틴과 녹차 추출물을 포함하는 항암 조성물 | |
| KR20060007368A (ko) | N-(3-클로로-1h-인돌-7-일)-4-설파모일벤젠설폰아미드를포함하는 약제 조성물 및 세포 증식 억제제 | |
| HK1240209A1 (en) | Processes for preparing oxathiazin-like compounds | |
| HK1240209B (zh) | 制备恶噻嗪样化合物的方法 | |
| HK1126147A (en) | Derivatives of sulindac, use thereof and preparation thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20231016 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20250425 Comment text: Request for Examination of Application |